These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21811804)

  • 1. A meta-analytic approach to estimating nocebo effects in neuropathic pain trials.
    Papadopoulos D; Mitsikostas DD
    J Neurol; 2012 Mar; 259(3):436-47. PubMed ID: 21811804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocebo effects in multiple sclerosis trials: a meta-analysis.
    Papadopoulos D; Mitsikostas DD
    Mult Scler; 2010 Jul; 16(7):816-28. PubMed ID: 20538704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.
    Häuser W; Sarzi-Puttini P; Tölle TR; Wolfe F
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):78-87. PubMed ID: 23137770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
    Häuser W; Bartram C; Bartram-Wunn E; Tölle T
    Clin J Pain; 2012 Jun; 28(5):437-51. PubMed ID: 22336767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice.
    Mitsikostas DD; Chalarakis NG; Mantonakis LI; Delicha EM; Sfikakis PP
    Eur J Neurol; 2012 May; 19(5):672-80. PubMed ID: 21973313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can insights from placebo and nocebo mechanisms studies improve the randomized controlled trial?
    Vase L
    Scand J Pain; 2020 Jul; 20(3):451-467. PubMed ID: 32609651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocebo in multiple sclerosis trials: A meta-analysis on oral and newer injectable disease-modifying treatments.
    Gklinos P; Papadopoulos D; Mitsikostas DD
    Mult Scler Relat Disord; 2019 Nov; 36():101389. PubMed ID: 31525626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.
    Mitsikostas DD; Mantonakis LI; Chalarakis NG
    Cephalalgia; 2011 Apr; 31(5):550-61. PubMed ID: 21216874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials.
    Zis P; Mitsikostas DD
    J Neurol Sci; 2015 Aug; 355(1-2):94-100. PubMed ID: 26073486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine for neuropathic pain in adults.
    Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials.
    Zis P; Shafiq F; Mitsikostas DD
    Seizure; 2017 Feb; 45():95-99. PubMed ID: 27978485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Kravvariti E; Kasdagli MI; Diomatari KM; Mouratidou P; Daskalakis K; Mitsikostas DD; Sfikakis PP; Yavropoulou MP
    Osteoporos Int; 2023 Mar; 34(3):585-598. PubMed ID: 36596944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta-Analysis.
    Wang S; Xiong Z; Cui Y; Fan F; Zhang S; Jia R; Hu Y; Li L; Zhang X; Han F
    Mov Disord; 2024 Mar; 39(3):585-595. PubMed ID: 38247265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocebo in clinical trials for depression: a meta-analysis.
    Mitsikostas DD; Mantonakis L; Chalarakis N
    Psychiatry Res; 2014 Jan; 215(1):82-6. PubMed ID: 24210741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine for chronic neuropathic pain in adults.
    Cooper TE; Chen J; Wiffen PJ; Derry S; Carr DB; Aldington D; Cole P; Moore RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011669. PubMed ID: 28530786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo, nocebo, and neuropathic pain.
    Vase L; Skyt I; Hall KT
    Pain; 2016 Feb; 157 Suppl 1(Suppl 1):S98-S105. PubMed ID: 26785162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature.
    Zis P; Mitsikostas DD
    Int Rev Neurobiol; 2018; 139():443-462. PubMed ID: 30146057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocebo response in dentistry: A systematic review and meta-analysis of adverse events in analgesic trials of third molar removal.
    Watanabe T; Sieg M; Lunde SJ; Persson M; Taneja P; Baad-Hansen L; Pigg M; Vase L
    J Oral Rehabil; 2023 Apr; 50(4):332-342. PubMed ID: 36648379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.